4//SEC Filing
McFadden Michael E. 4
Accession 0000899243-19-000779
CIK 0001740547other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:24 PM ET
Size
9.7 KB
Accession
0000899243-19-000779
Insider Transaction Report
Form 4
McFadden Michael E.
CCO of Urovant Sciences, Inc.
Transactions
- Award
Stock Option (Right to Buy)
2019-01-06+100,000→ 100,000 totalExercise: $6.88Exp: 2029-01-06→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]25% of the total shares underlying the option shall vest and become exercisable on January 2, 2020; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
Issuer
Urovant Sciences Ltd.
CIK 0001740547
Entity typeother
Related Parties
1- filerCIK 0001748333
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:24 PM ET
- Size
- 9.7 KB